C-OBIETrivium Vet
veterinary therapeutics, mTOR inhibition, sirolimus
modulatingsmall molecule
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-OBIE
C-OBIEC-OBIEveterinary therapeutics, mTOR inhibition, sirolimus
0-100 chain-logic scale · 15 dimensions · scored on public evidence
TriviumVet states that pets are part of the family and that when animals age or become ill, their suffering should be addressed with the best medicines and technologies available so they can live pain-free, healthy lives. The company presents itself as developing cutting-edge therapeutics, along with a pipeline of pharmaceuticals, medical devices, and diagnostics for companion animals.
SourceTriviumVet states that it exists to improve the lives of pets and their owners by developing innovative, clinically validated veterinary therapeutics for companion animals, especially for diseases with no approved treatment. The company says it believes effective veterinary medicines can be brought to market quickly and cost effectively by identifying unmet animal health needs, translating relevant human therapeutic research, creating species-specific formulations, and proving safety and efficacy to FDA and EMA standards in collaboration with veterinarians, specialists, regulators, and manufacturing partners.
SourceTriviumVet states that it exists to improve the lives of pets and their owners by developing innovative, clinically validated, registered therapeutics and diagnostics for companion animals, especially for diseases with no approved treatment. The company says it works with veterinarians and specialists worldwide and believes it can bring products to market quickly and cost effectively by identifying unmet animal diseases, translating relevant human therapeutic research, creating species-specific formulations and doses, and proving safety and efficacy to FDA and EMA standards.
SourceTriviumVet states that its purpose is to enrich the lives of pets and their owners by developing innovative, clinically validated, registered veterinary therapeutics and diagnostics for companion animals, especially for diseases with no available therapy. The company says it works with veterinarians and specialists worldwide and believes it can bring treatments to market quickly and cost effectively by identifying unmet diseases, adapting relevant human therapeutic research for animals, creating species-specific formulations, and demonstrating safety and efficacy to FDA and EMA standards.
Source